Inventor · disambiguated record
Christoph T. Ellebrecht
Also filed as: ELLEBRECHT CHRISTOPH T
9 granted patents·8 pending applications·9 citations·filing 2015–2025
82Inventor score
Top patents by PatentIndex Score
17 records- 0193US10301370B2Compositions and methods of chimeric autoantibody receptor T cellsUNIV PENNSYLVANIA·Filed 2015·Granted May 28, 2019·6 cites·16 claims
- 0285US11407803B2Compositions and methods of chimeric autoantibody receptor T cellsUNIV PENNSYLVANIA·Filed 2019·Granted Aug 9, 2022·1 cites·21 claims
- 0382US10738099B2Method of redirecting T cells to treat HIV infectionUNIV PENNSYLVANIA·Filed 2016·Granted Aug 11, 2020·2 cites·27 claims
- 0481US2023303653A1Compositions and methods of chimeric autoantibody receptor t cellsUNIV PENNSYLVANIA·Filed 2023·Application pending·0 cites
- 0579US2025084147A1Method of Redirecting T Cells to Treat HIV InfectionUNIV PENNSYLVANIA·Filed 2024·Application pending·0 cites
- 0675US11578113B2Compositions and methods of chimeric autoantibody receptor T cellsUNIV PENNSYLVANIA·Filed 2019·Granted Feb 14, 2023·0 cites·21 claims
- 0775US11407802B2Compositions and methods of chimeric autoantibody receptor T cellsUNIV PENNSYLVANIA·Filed 2019·Granted Aug 9, 2022·0 cites·14 claims
- 0875US11407804B2Compositions and methods of chimeric autoantibody receptor T cellsUNIV PENNSYLVANIA·Filed 2019·Granted Aug 9, 2022·0 cites·19 claims
- 0970US2024425564A1Compositions and methods of muscle specific kinase chimeric autoantibody receptor cellsUNIV PENNSYLVANIA·Filed 2024·Application pending·0 cites
- 1069US12215154B2Compositions and methods for targeting γδ T cells with chimeric antigen receptorsUNIV PENNSYLVANIA·Filed 2019·Granted Feb 4, 2025·0 cites·22 claims
- 1168US12122820B2Method of redirecting t cells to treat HIV infectionUNIV PENNSYLVANIA·Filed 2020·Granted Oct 22, 2024·0 cites·11 claims
- 1265US11905321B2Compositions and methods of muscle specific kinase chimeric autoantibody receptor cellsUNIV PENNSYLVANIA·Filed 2019·Granted Feb 20, 2024·0 cites·15 claims
- 1362US2025333695A1Methods for optimizing t cell immunotherapeutic effector and memory functionUNIV PENNSYLVANIA·Filed 2023·Application pending·0 cites
- 1458US2025179179A1Compositions and methods for targeting gamma delta t cells with chimeric antigen receptorsUNIV PENNSYLVANIA·Filed 2025·Application pending·0 cites
- 1551US2025375465A1Methods for affecting tissue-resident t cellsUNIV PENNSYLVANIA·Filed 2025·Application pending·0 cites
- 1647US2021161958A1Compositions and methods for treating melanoma with a chimeric antigen receptorUNIV PENNSYLVANIA·Filed 2019·Application pending·0 cites
- 1737US2023071283A1Compositions and methods for selective protein expressionGOLOSOV ANDREI·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →